Brief: Oryzon Publishes Results Of Observational Clinical Study On PMS Patients

ORYZON Genomics SA

05/03/2025 07:06

March 5 (Reuters) - Oryzon Genomics SA ORY.MC:

FINAL RESULTS OF OBSERVATIONAL CLINICAL STUDY ON PHELAN-MCDERMID SYNDROME (PMS) PATIENTS, A FORM OF AUTISM

VAFIDEMSTAT HAS DEMONSTRATED EFFICACY IN REDUCING AGITATION AND AGGRESSION IN A BASKET TRIAL INVOLVING PATIENTS

BASKET TRIAL INVOLVED PATIENTS WITH AUTISM SPECTRUM DISORDER (ASD), ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), AND BORDERLINE PERSONALITY DISORDER (BPD)

Source text: https://tinyurl.com/2dfs8upm

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))